Schaeffer's Options Center
Sponsored by:
Schaeffer's Daily Option Blog

by 3/29/2001 11:33 AM
Stocks quoted in this article:
According to Hoover's Online, Coca-Cola Enterprises (CCE – 18.03) is the world's top bottler and accounts for roughly three-fourths of the Coca-Cola (KO – 44.60) sold in North America.

In today's session, CCE has declined nearly 15 percent on heavy volume after revealing that its first-quarter loss will likely be 19 to 21 cents per share because of slowing sales in North America. The Street previously forecast that the company would lose eight cents per share during the reporting period. Moreover, CCE officials said it may also fall short of annual profit estimates.

The shares were subsequently greeted with a downgrade this morning, as Goldman Sachs Group lowered its rating on the equity to a "market performer" from a perch on its "recommended" list.

Technically speaking, the stock has suffered a notable bear gap this morning, breaching its 10-month moving average along the way. <

by 3/29/2001 11:24 AM
Stocks quoted in this article:
This morning we are seeing strength in the medical and biotech sectors. The AMEX Biotechnology Index (BTK – 478.4) and Morgan Stanley Healthcare Payors (HMO – 416.52) indices are each up almost five percent, after almost two hours of trading.

Standouts include Wellpoint Health Networks (WLP – 91.31) up 4.71 percent, Lifepoint Hospitals (LPNT – 34-3/8) up 5.79 percent, Genzyme General (GENZ – 93.25) up 3.85 percent, Vertex Pharmaceuticals (VRTX – 35-7/16) up 6.39 percent, Chiron (CHIR – 45-7/8) up 4.86 percent, and Protein Design Labs (PDLI – 42-1/2) up 5.59 percent.<

by 3/29/2001 11:09 AM
Stocks quoted in this article:
Panera Bread Company (PNRA – 24-3/8) owns and franchises around 250 bakery restaurants across the United States. The corporation continues to run a successful enterprise; last week PNRA officials announced that its February sales rose nearly 10 percent compared to last year. Yesterday evening, the firm boosted its 2001 income projection to 76 cents per share. This represents a 46-percent increase over 2000 earnings figures.

The equity has risen slightly in early trading today. PNRA has enjoyed recent support from its ascending 10-week moving average and is presently sitting less than 10 percent away from its former annual high in the 26-27 area. PNRA is not yet an optionable stock. <

by 3/29/2001 10:54 AM
Stocks quoted in this article:
Food and Drug Administration approval was announced late last night for Watson Pharmaceutical's (WPI – 53.50) Buspirone Hydrochloride tablets. Buspirone is an anti-anxiety drug that is a generic form of Bristol-Myers Squibb's (BMY - 60.49) BuSpar. WPI plans to launch Buspirone immediately, but does not see the sales of the new product affecting first-quarter earnings due to the limited number of days left in the quarter.

The shares gapped above their 10-day moving average, climbing back over the trendline for the first time in more than a week. WPI is currently facing resistance at its overhead 20-day moving average, which rests slightly below the 54 level. In contrast to the stock's climb, sentiment has grown more negative on the shares. Short interest on WPI has shot up by 37 percent from the last reporting period.

by 3/29/2001 9:31 AM
Stocks quoted in this article:
Delphi Automotive System (DPH – 13.94) announced that its restructuring plan would lead to job cuts up to 11,500. DPH plans to sell, close, or consolidate nine of its plants and downsize 40 other facilities. In addition, estimates for first-quarter revenue has been lowered. It is now expected to fall as much as $150 million below current Street estimates and up to 18 percent below earnings for the same period a year ago.

Since the beginning of February, the stock has been trading in a range between 14 and 15, but slipped to close below the lower end of this range yesterday. Combined with today's negative news, the stock may have trouble clinging to support in the 14 area.

From a sentiment standpoint, the number of shorted shares fell more than 59 percent from the last reporting period. This indicates a significant jump in the opinions of investors moving from pessimistic to optimistic.

Featured Brokers
Unusual Option Volume
Option Flow
Most Active Stocks
Most Active Option Strikes
Largest Open Interest

Partner Center

© 2015 Schaeffer's Investment Research, Inc. 5151 Pfeiffer Road, Suite 250, Cincinnati, Ohio 45242 Phone: (800) 448-2080 FAX: (513) 589-3810 Int'l Callers: (513) 589-3800 Email:

All Rights Reserved. Unauthorized reproduction of any SIR publication is strictly prohibited.

Market Data provided by | Data delayed 15-20 minutes unless otherwise indicated.